CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3 Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALN TTRSC in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02319005
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:52.005472+00:00
Published At: 2018-07-18T00:00:00+00:00
Record Updated At: 2018-07-18
Results Posted At: 2018-07-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)", "Amyloidosis, Hereditary", "Amyloid Neuropathies, Familial", "Amyloid Neuropathies", "Amyloidosis, Hereditary, Transthyretin-Related", "Familial Transthyretin Cardiac Amyloidosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-18"
protocolSection.identificationModule.nctId: "NCT02319005"
protocolSection.identificationModule.officialTitle: "A Phase 3 Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALN TTRSC in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-07-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.